Washington Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $730K | Sell |
|
|||||
|
2025
Q2 | $779K | Buy |
|
|||||
|
2025
Q1 | $487K | Sell |
|
|||||
|
2024
Q4 | $696K | Hold |
|
|||||
|
2024
Q3 | $588K | Buy |
|
|||||
|
2024
Q2 | $454K | Sell |
|
|||||
|
2024
Q1 | $552K | Sell |
|
|||||
|
2023
Q4 | $626K | Sell |
|
|||||
|
2023
Q3 | $647K | Hold |
|
|||||
|
2023
Q2 | $542K | Buy |
|
|||||
|
2023
Q1 | $506K | Hold |
|
|||||
|
2022
Q4 | $597K | Sell |
|
|||||
|
2022
Q3 | $690K | Hold |
|
|||||
|
2022
Q2 | $634K | Hold |
|
|||||
|
2022
Q1 | $609K | Hold |
|
|||||
|
2021
Q4 | $554K | Hold |
|
|||||
|
2021
Q3 | $623K | Hold |
|
|||||
|
2021
Q2 | $633K | Hold |
|
|||||
|
2021
Q1 | $632K | Hold |
|
|||||
|
2020
Q4 | $623K | Buy |
|
|||||
|
2020
Q3 | $519K | Buy |
|